BRPI0512732A - formulações tópicas para tratamento de doenças alérgicas - Google Patents

formulações tópicas para tratamento de doenças alérgicas

Info

Publication number
BRPI0512732A
BRPI0512732A BRPI0512732-7A BRPI0512732A BRPI0512732A BR PI0512732 A BRPI0512732 A BR PI0512732A BR PI0512732 A BRPI0512732 A BR PI0512732A BR PI0512732 A BRPI0512732 A BR PI0512732A
Authority
BR
Brazil
Prior art keywords
topical formulations
allergic diseases
treating allergic
ear
treatment
Prior art date
Application number
BRPI0512732-7A
Other languages
English (en)
Inventor
Mark R Hellberg
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BRPI0512732A publication Critical patent/BRPI0512732A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

FORMULAçõES TóPICAS PARA TRATAMENTO DE DOENçAS ALéRGICAS. A presente invenção refere-se a métodos para topicamente tratar doença alérgica dos olhos, ouvido ou nariz empregando compostos tricíclico, são descritos.
BRPI0512732-7A 2004-06-28 2005-06-27 formulações tópicas para tratamento de doenças alérgicas BRPI0512732A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58338004P 2004-06-28 2004-06-28
PCT/US2005/022940 WO2006004757A2 (en) 2004-06-28 2005-06-27 Topical formulations for treating allergic diseases

Publications (1)

Publication Number Publication Date
BRPI0512732A true BRPI0512732A (pt) 2008-04-08

Family

ID=35502431

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512732-7A BRPI0512732A (pt) 2004-06-28 2005-06-27 formulações tópicas para tratamento de doenças alérgicas

Country Status (11)

Country Link
US (1) US20050288283A1 (pt)
EP (1) EP1761259A2 (pt)
JP (1) JP2008504300A (pt)
KR (1) KR20070024618A (pt)
CN (1) CN1976694A (pt)
AU (1) AU2005259911A1 (pt)
BR (1) BRPI0512732A (pt)
CA (1) CA2569519A1 (pt)
MX (1) MXPA06014648A (pt)
WO (1) WO2006004757A2 (pt)
ZA (1) ZA200610350B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1757285A4 (en) * 2004-04-21 2007-11-07 Kyowa Hakko Kogyo Kk PREVENTIVE AND / OR THERAPEUTIC AGENT FOR CHRONIC SINUSITIS
US20060111436A1 (en) * 2004-11-23 2006-05-25 John Griffin Compositions and treatments for modulating kinase and/or HMG-CoA reductase
EP2067777B1 (en) * 2006-09-29 2013-08-14 Nippon Zoki Pharmaceutical Co., Ltd. Oxepin derivative
ES2581833T3 (es) * 2009-02-05 2016-09-07 Zach System S.P.A. Proceso para preparación de olopatadina y/o una sal farmacéuticamente aceptable de la misma
CN104603775B (zh) * 2012-08-14 2018-06-19 华为技术有限公司 事务的回滚方法和装置，以及关系数据库管理系统
CN106117176B (zh) * 2016-06-24 2018-12-11 四川大学 二氢双苯并恶庚衍生物及其组合物与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
BR0110852A (pt) * 2000-05-19 2003-02-11 Alcon Inc Composições que contêm um derivado dissulfeto de benzamida para tratamento de doenças alérgicas
EP1289945B1 (en) * 2000-05-19 2004-08-04 Alcon Inc. Aniline disulfide derivatives for treating allergic diseases
PL365457A1 (en) * 2000-05-19 2005-01-10 Alcon, Inc. Disulfide derivatives useful for treating allergic diseases
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration

Also Published As

Publication number Publication date
MXPA06014648A (es) 2007-02-12
AU2005259911A1 (en) 2006-01-12
KR20070024618A (ko) 2007-03-02
CN1976694A (zh) 2007-06-06
EP1761259A2 (en) 2007-03-14
ZA200610350B (en) 2008-12-31
WO2006004757A2 (en) 2006-01-12
CA2569519A1 (en) 2006-01-12
WO2006004757A3 (en) 2006-03-09
JP2008504300A (ja) 2008-02-14
US20050288283A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
NL300933I2 (nl) Letermovir
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
BRPI0413245A (pt) compostos heteroarila de 6 membros para o tratamento de distúrbio neurodegenerativos
BRPI0518904A2 (pt) formulaÇÕes de nepafenac tàpicas
BR0315158A (pt) Compostos de pirazol para o tratamento de distúrbios neurodegenarativos
BRPI0514841A (pt) inibidores de piridila da sinalização de hedgehog, processo de preparação dos mesmos e composição compreendendo os referidos inibidores
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
EA201071243A1 (ru) Комбинированные композиции для лечения болезни альцгеймера и родственных заболеваний зонизамидом и акампросатом
CR10072A (es) Derivados de pirimidinil-aril-urea que son inhibidores de fgf
MA31167B1 (fr) Inhibiteurs de l'activite de akt
WO2007075598A3 (en) N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
BRPI0509069A (pt) compostos de imidazol para o tratamento de distúrbios neurodegenerativos
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
EA200700909A1 (ru) Азаиндолкарбоксамиды
WO2006058868A3 (de) Substituierte pteridine zur behandlung von entzündlichen erkrankungen
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
BRPI0506970B8 (pt) derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior
ATE489948T1 (de) Behandlung von autoimmunkrankheiten
BRPI0509477A (pt) compostos de sulfonamida para o tratamento de distúrbios neurodegenerativos
BR0307574A (pt) Derivados de nicotinamida úteis como inibidores de pde4
BRPI0413709A (pt) compostos para o tratamento de distúrbios neurodegenerativos
BRPI0411098A (pt) benzofuranocarboxamidas, com atividade pi3k, como agentes terapêuticos
BRPI0512732A (pt) formulações tópicas para tratamento de doenças alérgicas
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A E 6A AUNIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2139 DE 03/01/2012.